3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Neoplasm Metastasis
2
Skin Diseases
1
Sexuality
1
Patient Acceptance of Health Care
1
Neoplasms
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Interventions
methyl 5-aminolevulinate
1
exemestane
1
Sodium Chloride
1
Fluorouracil
1
Everolimus
1
Botulinum Toxins, Type A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Skin Diseases
×
exemestane
×
Clear all
NCT01743560
2019-07-18
4EVERUK
Novartis
Phase 4
Completed
52 enrolled
16 charts